NFKB1 and Alzheimer disease: Recent research indicates that Sinomenine contributes to the equilibrium between the brain and gut through the modulation of the cholinergic anti-inflammatory pathway (CAP) and the inhibition of the TLR4/NF-κB signaling pathway in a mouse model of Alzheimer’s disease (AD) (191).